Skip to main content

Advertisement

ADVERTISEMENT

Recovery

Melissa Sahlin, LISW-S, LCSW
News
11/20/2023
Tom Valentino, Digital Managing Editor
BrightView Chief Clinical Officer Melissa Sahlin, LISW-S, LCSW, explains how practitioners can improve virtual-based therapy by using the right equipment and familiarizing patients with their telehealth platform.
BrightView Chief Clinical Officer Melissa Sahlin, LISW-S, LCSW, explains how practitioners can improve virtual-based therapy by using the right equipment and familiarizing patients with their telehealth platform.
BrightView Chief Clinical...
11/20/2023
Addiction Professional
News
11/14/2023
Tom Valentino, Digital Managing Editor
About 1 in 4 people in the US who are at least 12 years of age used illicit drugs within the past year and more than 1 in 6 had a substance use disorder during the same period, according to data from the 2022 National Survey on Drug Use and...
About 1 in 4 people in the US who are at least 12 years of age used illicit drugs within the past year and more than 1 in 6 had a substance use disorder during the same period, according to data from the 2022 National Survey on Drug Use and...
About 1 in 4 people in the US...
11/14/2023
Addiction Professional
Steven Proctor, PhD
News
11/10/2023
Tom Valentino, Digital Managing Editor
Often associated with treatment for stimulant addiction, contingency management programs can work as a complement to medication-assisted treatment for other substance use disorders as well, says Steven Proctor, PhD.
Often associated with treatment for stimulant addiction, contingency management programs can work as a complement to medication-assisted treatment for other substance use disorders as well, says Steven Proctor, PhD.
Often associated with treatment...
11/10/2023
Addiction Professional
News
11/08/2023
Tom Valentino, Digital Managing Editor
A clinical trial conducted by NIDA researchers has found that a group of brain regions is activated after a drug is taken intravenously, but not when the same drug is taken orally.
A clinical trial conducted by NIDA researchers has found that a group of brain regions is activated after a drug is taken intravenously, but not when the same drug is taken orally.
A clinical trial conducted by...
11/08/2023
Addiction Professional
News
11/07/2023
Tom Valentino, Digital Managing Editor
Researchers from West Virginia University and the University of Virginia are studying the use of low-intensity focused ultrasound as an intervention to reduce cravings for multiple substances.
Researchers from West Virginia University and the University of Virginia are studying the use of low-intensity focused ultrasound as an intervention to reduce cravings for multiple substances.
Researchers from West Virginia...
11/07/2023
Addiction Professional
Christopher Nicholas, PhD
News
10/31/2023
Tom Valentino, Digital Managing Editor
With drug overdose deaths continuing to climb, Sana Symposium presenter Christopher Nicholas, PhD, said studies suggest that incorporating the use of psychedelics into treatment modalities could improve outcomes.
With drug overdose deaths continuing to climb, Sana Symposium presenter Christopher Nicholas, PhD, said studies suggest that incorporating the use of psychedelics into treatment modalities could improve outcomes.
With drug overdose deaths...
10/31/2023
Psych Congress Network
News
10/27/2023
Tom Valentino, Digital Managing Editor
A new study has used neuroimaging to show how cocaine addiction impairs the brain’s ability to process and respond to reward-related information, complicating addiction recovery.
A new study has used neuroimaging to show how cocaine addiction impairs the brain’s ability to process and respond to reward-related information, complicating addiction recovery.
A new study has used...
10/27/2023
Addiction Professional
News
10/19/2023
Tom Valentino, Digital Managing Editor
Discovery Behavioral Health has launched an artificial intelligence platform that it hopes will reduce relapse rates among not only its own patients, but potentially the clients of other providers across the industry as well.
Discovery Behavioral Health has launched an artificial intelligence platform that it hopes will reduce relapse rates among not only its own patients, but potentially the clients of other providers across the industry as well.
Discovery Behavioral Health has...
10/19/2023
Behavioral Healthcare Executive
News
10/18/2023
Tom Valentino, Digital Managing Editor
OUD patients who initiated buprenorphine treatment through telehealth have been found more likely to remain engaged with treatment longer than those who began treatment in a non-telehealth setting, according to a new NIDA study.
OUD patients who initiated buprenorphine treatment through telehealth have been found more likely to remain engaged with treatment longer than those who began treatment in a non-telehealth setting, according to a new NIDA study.
OUD patients who initiated...
10/18/2023
Addiction Professional
Kelly Olson, PhD
News
10/06/2023
Tom Valentino, Digital Managing Editor
Practitioners must be aware of concurrent use of non-prescribed, illicit substances that can negatively impact treatment and potentially harm patients being treated with medications for opioid use disorder, says Millennium Health Director of...
Practitioners must be aware of concurrent use of non-prescribed, illicit substances that can negatively impact treatment and potentially harm patients being treated with medications for opioid use disorder, says Millennium Health Director of...
Practitioners must be aware of...
10/06/2023
Addiction Professional

Advertisement

Advertisement